Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo

BioFactors

Volumn 41, Issue 5, 2015, Pages 314-323

  Leong, Pou Kuan ^a   Ko, Kam Ming ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

Caspase 1; Inflammasome; Macrophage; Schisandrin B; Thioredoxin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALUMINUM POTASSIUM SULFATE; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SCHIZANDRIN B; STRESS ACTIVATED PROTEIN KINASE 1; THIOREDOXIN; TRANSCRIPTION FACTOR NRF2; CYCLOOCTANE DERIVATIVE; LIGNAN; POLYCYCLIC HYDROCARBON;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CELL LINE; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; INSTITUTE FOR CANCER RESEARCH MOUSE; MACROPHAGE; METABOLISM;

ALUM COMPOUNDS; ANIMALS; CASPASE 1; CELL LINE; CELLS, CULTURED; CYCLOOCTANES; FEMALE; INFLAMMASOMES; INTERLEUKIN-1BETA; LIGNANS; MACROPHAGES; MICE; MICE, INBRED ICR; PERITONITIS; POLYCYCLIC COMPOUNDS; REACTIVE OXYGEN SPECIES; THIOREDOXINS;

EID: 84945493966     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1224     Document Type: Article

References (32)

1. Medzhitov, R., and Janeway, C. A. (1999) Innate immunity: the virtues of a nonclonal system of recognition. Cell 91, 295-298.
2. Matzinger, P. (1994) Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991-1045.
3. Humphreys, B. D., Rice, J., Kertesy, S. B., and Dubyak, G. R. (2000) Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J. Biol. Chem., 275, 26792-26798.
4. Okin, D., and Medzhitov, R. (2012) Evolution of inflammatory diseases. Curr. Biol., 22, R733-R740.
5. Strowig, T., Henao-Mejia, J., Elinav, E., and Flavell, R. (2012) Inflammasomes in health and disease. Nature. 481, 278-286.
6. Menu, P., and Vince, J. E. (2011) The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin. Exp. Immunol. 166, 1-15.
7. Youm, Y. H., Grant, R. W., McCabe, L. R., Albarado, D. C., Nguyen, K. Y., et al. (2013) Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 18, 519-532.
8. Chiu, P. Y., Luk, K. F., Leung, H. Y., Ng, K. M., and Ko, K. M. (2008) Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes. Life Sci. 82, 1092-1101.
9. Leong, P. K., Chen, N., and Ko, K. M. (2012) Mitochondrial decay in ageing: 'Qi-invigorating' schisandrin B as a hormetic agent for mitigating age-related diseases. Clin. Exp. Pharmacol. Physiol. 39, 256-264.
10. Ko, K. M., Chen, N., Leung, H. Y., Leong, E. P., Poon, M. K., et al. (2008) Long-term schisandrin B treatment mitigates age-related impairments in mitochondrial antioxidant status and functional ability in various tissues, and improves the survival of aging C57BL/6J mice. Biofactors 34, 331-342.
11. Oh, S. Y., Kim, Y. H., Bae, D. S., Um, B. H., Pan, C. H., et al. (2010) Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis. Biosci. Biotechnol. Biochem. 74, 285-291.
12. Checker, R., Patwardhan, R. S., Sharma, D., Menon, J., Thoh, M., et al. (2012) Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-κB. Free Radic. Biol. Med. 53, 1421-1430.
13. Zeng, K. W., Zhang, T., Fu, H., Liu, G. X., and Wang, X. M. (2012) Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia. Eur. J. Pharmacol. 692, 29-37.
14. Chiu, P. Y., Luk, K. F., Leung, H. Y., Ng, K. M., and Ko, K. M. (2009) Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and associated changes in the Ca(2+)-induced mitochondrial permeability transition and mitochondrial membrane potential in AML12 hepatocytes. Phytother. Res. 23, 1592-1602.
15. Davies, J. Q., and Gordon, S. (2005) Isolation and culture of murine macrophages. Methods Mol. Biol. 290, 91-103.
16. Zhang, X., Goncalves, R., and Mosser, D. M. in: Coligan, J. E., Bierer, B., Margulies, D. H., Shevach, E. M., and Strober, W., eds. (2008) Current Protocols in Immunology. pp. 14.1.1-14.1.14, Wiley, New York.
17. Leong, P. K., Chiu, P. Y., Chen, N., Leung, H. Y., and Ko, K. M. (2011) Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in AML12 hepatocytes. Free Radic. Res. 45, 483-495.
18. Jin, J., Yu, Q., Han, C., Hu, X., Xu, S., et al. (2013) LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition. Nat. Commun. 4, 2075
19. Chiu, P. Y., and Ko, K. M. (2006) Schisandrin B-induced increase in cellular glutathione level and protection against oxidant injury are mediated by the enhancement of glutathione synthesis and regeneration in AML12 and H9c2 cells. Biofactors. 26, 221-230.
20. Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., et al. (2009) Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183, 787-791.
21. Tschopp, J., and Schroder, K. (2010) NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol. 10, 210-215.
22. Pelegrin, P., Barroso-Gutierrez, C., and Surprenant, A. (2008) P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J. Immunol. 180, 7147-7157.
23. Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., et al. (2011) Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408-415.
24. Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., et al. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188.
25. Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., et al. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357-1361.
26. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695.
27. Galkina, E., and Ley, K. (2009) Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 27, 165-197.
28. Chiu, P. Y., Chen, N., Leong, P. K., Leung, H. Y., and Ko, K. M. (2011) Schisandrin B elicits a glutathione antioxidant response and protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway in H9c2 cells. Mol. Cell. Biochem. 350, 237-250.
29. Ohshima, Y., Kitami, A., Kawano, A., Tsukimoto, M., and Kojima, S. (2011) Induction of extracellular ATP mediates increase in intracellular thioredoxin in RAW264.7 cells exposed to low-dose γ-rays. Free Radic. Biol. Med. 51, 1240-1248.
30. Torii, M., Wang, L., Ma, N., Saito, K., Hori, T., et al. (2010) Thioredoxin suppresses airway inflammation independently of systemic Th1/Th2 immune modulation. Eur. J. Immunol. 40, 787-796.
31. Moll, M., and Kuemmerle-Deschner, J. B. (2013) Inflammasome and cytokine blocking strategies in autoinflammatory disorders. Clin. Immunol. 147, 242-275.
32. Ozaki, E., Campbell, M., and Doyle, S. L. (2015) Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 8, 15-27.